Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity (vol 11, pg 417, 2001)

被引：0
|
作者：
Wennerholm, A
Johansson, I
Hidestrand, M
Bertilsson, L
Gustafsson, LL
IngelmanSundberg, M
机构：
来源：
PHARMACOGENETICS | 2001年 / 11卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：743 / 743
页数：1
相关论文
共 27 条
  • [1] Characterization of the CYP2D6*29 allele commonly present in a blade Tanzanian population causing reduced catalytic activity
    Wennerholm, A
    Johansson, I
    Hidestrand, M
    Bertilsson, L
    Gustafsson, LL
    Ingelman-Sundberg, M
    PHARMACOGENETICS, 2001, 11 (05): : 417 - 427
  • [2] Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population
    Bathum, L
    Skjelbo, E
    Mutabingwa, TK
    Madsen, H
    Horder, M
    Brosen, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (03) : 395 - 401
  • [3] Resequencing CYP2D6 gene in Indian population: CYP2D6*41 identified as the major reduced function allele
    Manoharan, Aarthi
    Shewade, Deepak Gopal
    Ravindranath, Pradeep Anand
    Rajkumar, Ravi Philip
    Ramprasad, Vedam L.
    Adithan, Surendiran
    Damodaran, Solai Elango
    PHARMACOGENOMICS, 2019, 20 (10) : 719 - 730
  • [4] Common mutant alleles of CYP2D6 causing the defect of CYP2D6 enzyme activity in a Japanese population
    Ishiguro, A
    Kubota, T
    Sasaki, H
    Yamada, Y
    Iga, T
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 414 - U3
  • [5] Phenotype and genotype analysis of debrisoquine hydroxylase (CYP2D6) in a black Zimbabwean population - Reduced enzyme activity and evaluation of metabolic correlation of CYP2D6
    Masimirembwa, C
    Hasler, J
    Bertilssons, L
    Johansson, I
    Ekberg, O
    IngelmanSundberg, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (02) : 117 - 122
  • [6] CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes
    Byeon, Ji-Young
    Kim, Young-Hoon
    Lee, Choong-Min
    Kim, Se-Hyung
    Chae, Won-Ki
    Jung, Eui-Hyun
    Choi, Chang-Ik
    Jang, Choon-Gon
    Lee, Seok-Yong
    Bae, Jung-Woo
    Lee, Yun Jeong
    ARCHIVES OF PHARMACAL RESEARCH, 2018, 41 (09) : 921 - 930
  • [7] CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes
    Ji-Young Byeon
    Young-Hoon Kim
    Choong-Min Lee
    Se-Hyung Kim
    Won-Ki Chae
    Eui-Hyun Jung
    Chang-Ik Choi
    Choon-Gon Jang
    Seok-Yong Lee
    Jung-Woo Bae
    Yun Jeong Lee
    Archives of Pharmacal Research, 2018, 41 : 921 - 930
  • [8] A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: Association with diminished debrisoquine hydroxylase activity
    Masimirembwa, C
    Persson, I
    Bertilsson, L
    Hasler, J
    IngelmanSundberg, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (06) : 713 - 719
  • [9] The CYP2D6 humanized mouse:: effect of the human CYP2D6 transgene and HNF4α on the disposition of debrisoquine in the mouse (vol 60, pg 1260, 2001)
    Corchero, J
    Granvil, CP
    Akiyama, TE
    Hayhurst, GP
    Pimprale, S
    Feigenbaum, L
    Idle, JR
    Gonzalez, FJ
    MOLECULAR PHARMACOLOGY, 2002, 61 (01) : 248 - 248
  • [10] Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians (vol 45, pg 315, 1998)
    Simooya, OO
    Sijumbila, G
    Lennard, MS
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (04) : 414 - 414
123